3-179185476-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006218.4(PIK3CA):​c.-76-13274C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.568 in 152,084 control chromosomes in the GnomAD database, including 25,741 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. The gene PIK3CA is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.57 ( 25741 hom., cov: 32)

Consequence

PIK3CA
NM_006218.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -5.78

Publications

25 publications found
Variant links:
Genes affected
PIK3CA (HGNC:8975): (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. This gene has been found to be oncogenic and has been implicated in cervical cancers. A pseudogene of this gene has been defined on chromosome 22. [provided by RefSeq, Apr 2016]
PIK3CA Gene-Disease associations (from GenCC):
  • overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • megalencephaly-capillary malformation-polymicrogyria syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • vascular malformation
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • Cowden disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Cowden syndrome 5
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • familial ovarian cancer
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.03).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.747 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006218.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PIK3CA
NM_006218.4
MANE Select
c.-76-13274C>T
intron
N/ANP_006209.2P42336

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PIK3CA
ENST00000263967.4
TSL:2 MANE Select
c.-76-13274C>T
intron
N/AENSP00000263967.3P42336
PIK3CA
ENST00000955190.1
c.-76-13274C>T
intron
N/AENSP00000625249.1
PIK3CA
ENST00000876545.1
c.-76-13274C>T
intron
N/AENSP00000546604.1

Frequencies

GnomAD3 genomes
AF:
0.568
AC:
86258
AN:
151966
Hom.:
25706
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.754
Gnomad AMI
AF:
0.738
Gnomad AMR
AF:
0.508
Gnomad ASJ
AF:
0.563
Gnomad EAS
AF:
0.222
Gnomad SAS
AF:
0.466
Gnomad FIN
AF:
0.434
Gnomad MID
AF:
0.661
Gnomad NFE
AF:
0.519
Gnomad OTH
AF:
0.578
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.568
AC:
86351
AN:
152084
Hom.:
25741
Cov.:
32
AF XY:
0.559
AC XY:
41519
AN XY:
74310
show subpopulations
African (AFR)
AF:
0.754
AC:
31321
AN:
41518
American (AMR)
AF:
0.508
AC:
7770
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.563
AC:
1952
AN:
3468
East Asian (EAS)
AF:
0.222
AC:
1145
AN:
5166
South Asian (SAS)
AF:
0.466
AC:
2239
AN:
4804
European-Finnish (FIN)
AF:
0.434
AC:
4583
AN:
10552
Middle Eastern (MID)
AF:
0.663
AC:
195
AN:
294
European-Non Finnish (NFE)
AF:
0.519
AC:
35260
AN:
67970
Other (OTH)
AF:
0.574
AC:
1213
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1849
3698
5548
7397
9246
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
730
1460
2190
2920
3650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.539
Hom.:
46774
Bravo
AF:
0.583
Asia WGS
AF:
0.363
AC:
1260
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.33
DANN
Benign
0.37
PhyloP100
-5.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2677760; hg19: chr3-178903264; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.